ENTRY       D10793            Mixture   Drug
NAME        Sodium picosulfate hydrate, magnesium oxide and citric acid, anhydrous;
            Picoprep (TN);
            Prepopik (TN);
            Clenpiq (TN)
PRODUCT     CLENPIQ (Ferring Pharmaceuticals)
            CLENPIQ (Ferring Pharmaceuticals)
  GENERIC   SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID (Camber Pharmaceuticals)
COMPONENT   Sodium picosulfate hydrate [DR:D01612], Magnesium oxide [DR:D01167], Citric acid, anhydrous [DR:D00037]
REMARK      Therapeutic category: 7990
            ATC code: A06AB58
            Product: D10793<JP/US>
EFFICACY    Laxative
COMMENT     Cleansing of the colon as a preparation for colonoscopy
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A06 DRUGS FOR CONSTIPATION
               A06A DRUGS FOR CONSTIPATION
                A06AB Contact laxatives
                 A06AB58 Sodium picosulfate, combinations
                  D10793  Sodium picosulfate hydrate, magnesium oxide and citric acid, anhydrous &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Gastrointestinal Agents
              Gastrointestinal Agents, Other
               Sodium Picosulfate/ Magnesium Oxide/ Anhydrous Citric Acid
                D10793  Sodium picosulfate hydrate, magnesium oxide and citric acid, anhydrous
            Therapeutic category of drugs in Japan [BR:br08301]
             7  Agents not mainly for therapeutic purpose
              79  Other agents not mainly for therapeutic purpose
               799  Miscellaneous
                7990  Miscellaneous
                 D10793  Sodium picosulfate hydrate, magnesium oxide and citric acid, anhydrous
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10793
DBLINKS     PubChem: 316933529
///
